CMS has awarded $8.6 million in funding to 30 states and the District of Columbia to help stabilize health insurance markets. The funding is part of $250 million earmarked for State Rate Review Grants to improve the process for how sates review proposed health insurance rates.

Several major pharmacy benefit managers (PBMs), functional middlemen that negotiate drug prices with manufacturers, say they’ve received no commitments from big drug makers to lower prices, The Hill reported.

Days after the state of New York filed suit against the manufacturer of a powerful opioid, President Donald Trump stated he’d like to see a federal lawsuit against more opioid makers.

In a new scholarship initiative, medical students will be able to attend New York University School of Medicine tuition free, regardless of need or merit.

Younger nurses are interested in getting higher degrees, according to a recent survey from AMN Healthcare.

Arkansas’ Medicaid work requirements are facing major problems. During the first month of implementation in June and July, more than 5,000 residents failed to follow through on reporting that they actually worked 80 hours.

Senator Chuck Grassley, R-Iowa, has asked the U.S. Department of Justice for heightened scrutiny over two significant healthcare deals currently underway, citing limited competition and high drug pricing concerns in a letter.

Express Scripts, the largest pharmacy benefits management company in the United States with annual revenue of $100 billion, looks like it’s trying to diversify its business offerings. In an interview with Reuters, Steve Miller, chief medical officer of Express Scripts, confirmed the organization is in negotiations with biotechnology companies to exclusively distribute hemophilia therapies.